Developed tumors were further validated by the expression of GPC3 (an HCC biomarker) and CK19 (an intrahepatic cholangiocarcinoma biomarker) (Figure S1F) 28, 29. This evidence concerns the gene GPC3 and cholangiocarcinoma.